Michelle Longmire

Dr. Michelle Longmire is mission-driven to accelerate the development of new therapies for disease as the founder and CEO of Medable, a Stanford-trained physician-scientist who identified critical barriers to drug development and founded Medable to pioneer a new category of clinical trial technologies that remove traditional roadblocks to participation and radically accelerate the research process. Medable is now the industry leader in decentralized and direct-to-patient research, with the ability to serve patients in more than 120 languages across 60 countries and all therapeutic areas.

After struggling to access patients in her own research in rare skin diseases, Dr. Longmire set out to solve this long-standing challenge in clinical research, rallying stakeholders, partners, and developers to launch Medable with the shared vision of radically increasing the number of effective therapies reaching people each year. She completed her dermatology residency at Stanford University Medical Center and held a postdoctoral research fellowship at Stanford University School of Medicine, with earlier research experience at the Howard Hughes Medical Institute, the National Cancer Institute, and Los Alamos National Laboratory. Fast Company named her one of the 100 most creative people in business, recognizing her inventive approach to health data systems and her ability to disrupt traditional models in clinical development.